Zacks Investment Research on MSN
MMED's latest study supports the strength of 780G SmartGuard algorithm
MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes ...
Twenty-four adult participants with type 1 diabetes were randomized to use either the Simplera Sync™ or Instinct sensor for a six-week period, then crossed over to the alternate sensor for an ...
The original version of this story appeared in Quanta Magazine. Computer scientists often deal with abstract problems that are hard to comprehend, but an exciting new algorithm matters to anyone who ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results